cCCLE Frequency
Hotspot Variant
FDA Approved Drugs
Locus
Summary: EGFR is a transmembrane glycoprotein that is a member of the protein kinase superfamily. This protein is a receptor for members of the epidermal growth factor family. Overexpression or mutations in this gene are associated with various cancers, particularly Lung Adenocarcinoma and Glioblastoma. In the cCCLE cohort, it shows a distinctive hotspot enrichment in East Asian NSCLC models.
Select Model Subset
Cohort Definition
18.4%
Hotspot: L858R
42.8 TPM
Highest: Liver models
24 Models
Status: Deep Amplification
5 Events
Frequent: EGFR-SEPT14
Mutation Landscape (EGFR)
RefSeq: NM_005228 | 1,210 Amino Acids
cCCLE Freq
18.4%
Total Models
108 / 580
A. Somatic Mutation Hotspots
B. Cohort Waterfall (Mutated Models)
Ranked by Variant TypeExpression vs. Copy Number
Correlation across multiple RNA biotypes
mRNA Expression Correlation
R = 0.78| Model Name | Lineage | mRNA (TPM) | Copy Number (log2) | Action |
|---|---|---|---|---|
| Hep-G2 | Liver | 12.84 | +1.92 | Profile → |
Fusion & Structural Variation
Large-scale Genomic Rearrangements
Structural Variant Event List
| Model | Event Type | Breakpoints (5' ⟷ 3') | Frame Status | Details |
|---|---|---|---|---|
| U-87 MG | Fusion | EGFR(e24) ⟷ SEPTIN14(e10) | In-Frame | cCCLE Internal |
| A549 | Deletion (SV) | Chr7:55,120,442 ⟷ 55,142,301 | — | Exon 2-7 Loss |